Quality by Design Approach for Development of W/O Type Microemulsion-Based Transdermal Systems for Atenolol

被引:7
作者
Dhingani, Anjali [1 ]
Patel, Jaydeep [1 ]
Garala, Kevin [1 ]
Raval, Mihir [2 ]
Dharamsi, Abhay [3 ]
机构
[1] Atmiya Inst Pharm, Dept Pharmaceut, Rajkot 360005, Gujarat, India
[2] Saurashtra Univ, Dept Pharmaceut Sci, Rajkot 360005, Gujarat, India
[3] Maliba Pharm Coll, Dept Pharmaceut, Surat, Gujarat, India
关键词
Atenolol; transdermal drug delivery; principal component analysis; D-optimal design; thickening agents; microemulsion; quality by design; IN-VIVO; PART II; DELIVERY; SKIN; OPTIMIZATION; FORMULATION; PERMEATION; COMPONENT; VITRO; GEL;
D O I
10.1080/01932691.2013.802242
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
The objective of the present investigation was to develop microemulsion-based transdermal systems of highly water soluble drug, Atenolol, by quality by design technique. Atenolol-loaded W/O microemulsions were optimized using D-optimal design with concentrations of oil, surfactants mixture, and water as independent variables, which was converted into microemulsion-based gel (MBG). The results of in vitro permeation of the optimized batch of Atenolol-loaded MBG revealed significant increase in permeability parameters as compared to its convention gel. All results suggested suitability of W/O type MEs as carriers for transdermal delivery of highly water soluble drug, Atenolol.
引用
收藏
页码:619 / 640
页数:22
相关论文
共 44 条
[31]   Multivariate data analysis in pharmaceutics: A tutorial review [J].
Rajalahti, Tarja ;
Kvalheim, Olav M. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2011, 417 (1-2) :280-290
[32]   What is principal component analysis? [J].
Ringner, Markus .
NATURE BIOTECHNOLOGY, 2008, 26 (03) :303-304
[33]   Understanding deformation mechanisms during powder compaction using principal component analysis of compression data [J].
Roopwani, Rahul ;
Buckner, Ira S. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2011, 418 (02) :227-234
[34]   Temperature-Sensitive Microemulsion Gel: An Effective Topical Delivery System for Simultaneous Delivery of Vitamins C and E [J].
Rozman, Branka ;
Zvonar, Alenka ;
Falson, Francoise ;
Gasperlin, Mirjana .
AAPS PHARMSCITECH, 2009, 10 (01) :54-61
[35]   A modern approach for controlled transdermal delivery of diflunisal: optimization and in vivo evaluation [J].
Sallam, Marwa Ahmed ;
Motawaa, Adel Mohamed ;
Mortada, Sana Mohamed .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2013, 39 (04) :600-610
[36]   Transdermal delivery of anticancer drug caffeine from water-in-oil nanoemulsions [J].
Shakeel, Faiyaz ;
Ramadan, Wafa .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2010, 75 (01) :356-362
[37]   Optimizing drug delivery systems using systematic "Design of experiments." Part I: Fundamental aspects [J].
Singh, B ;
Kumar, R ;
Ahuja, N .
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2005, 22 (01) :27-105
[38]   Optimizing drug delivery systems using systematic "design of experiments." - Part II: Retrospect and prospects [J].
Singh, B ;
Dahiya, M ;
Saharan, P ;
Ahuja, N .
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2005, 22 (03) :215-293
[39]  
Tenormin, 2012, PRESCRIBING INFORM
[40]   Quercetin in w/o microemulsion:: In vitro and in vivo skin penetration and efficacy against UVB-induced skin damages evaluated in vivo [J].
Vicentini, Fabiana T. M. C. ;
Simi, Thais R. M. ;
Del Ciampo, Jose O. ;
Wolga, Nilce O. ;
Pitol, Dimitrius L. ;
Iyomasa, Mamie M. ;
Bentley, M. Vitoria L. B. ;
Fonseca, Maria J. V. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2008, 69 (03) :948-957